PCV75 - AN UPDATED COST-EFFECTIVENESS PAIRWISE ANALYSIS OF APIXABAN AND WARFARIN FOR STROKE PREVENTION IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION IN FRANCE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.621
https://www.valueinhealthjournal.com/article/S1098-3015(18)33921-4/fulltext
Section Title :
Section Order :
39
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33921-4&doi=10.1016/j.jval.2018.09.621